FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20479011000001100: Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68944701000001110 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68944801000001118 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Is a Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solution.oral ontology form and route true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Is a Product containing magnesium glycerophosphate false Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has active ingredient Magnesium glycerophosphate false Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Has basis of strength substance Magnesium false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Drug Tariff Special Order) Is a True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml Has VMP True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has VMP True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Inferred relationship Existential restriction modifier
MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution (TriOn Pharma Ltd) Is a True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start